| Stage | SM | % of rev | CRC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.5B | 100.00% | $1.3B | 100.00% | SM ×1.93 |
| Gross profit | $1.9B | 77.76% | $1.2B | 95.76% | CRC +18.0pp |
| Operating income | $1.5B | 59.84% | $511M | 39.40% | SM +20.4pp |
| Pre-tax income | $1.4B | 55.56% | $458M | 35.31% | SM +20.2pp |
| Net income | $1.1B | 42.84% | $514M | 39.63% | SM +3.2pp |
| Stage | SM | CRC | Gap · A − B |
|---|---|---|---|
| Revenue | $2.5B100.00% | $1.3B100.00% | SM ×1.93 |
| Gross profit | 77.76%$1.9B | 95.76%$1.2B | CRC +18.0pp |
| Operating income | 59.84%$1.5B | 39.40%$511M | SM +20.4pp |
| Pre-tax income | 55.56%$1.4B | 35.31%$458M | SM +20.2pp |
| Net income |
| 42.84%$1.1B |
| 39.63%$514M |
| SM +3.2pp |
No disclosed counterparties: CRC.
None